Categories: Health

World’s 1st Living Lung Transplant to COVID Patient Conducted in Japan

KYOTO, April 9 – Kyoto University Hospital said Thursday it has performed the world’s first living donor lung transplant into a patient with lung damage from the novel coronavirus.

The COVID-19 patient, a woman from the Kansai western Japan region, is now in the intensive care unit, and her husband and son, who gave her parts of their lungs, are in stable conditions after the surgery, conducted on Wednesday, Jiji Press reported the hospital said.

Surgeries to transplant lungs from brain-dead donors to patients suffering lung damage related to the COVID-19 disease have been carried out in China, Europe and the United States, according to the hospital.

The woman became infected with the virus late last year. After her respiratory condition deteriorated while she was undergoing treatment at a different hospital in Kansai, the woman was placed on an extracorporeal membrane oxygenation, or ECMO, machine, it added.

Later, due to the aftereffects of novel coronavirus-induced pneumonia, both of her lungs became stiff and small, and almost non-functional.

The woman tested negative for the virus later, but she was alive only because of ECMO, and her recovery was seen as difficult unless she had a lung transplant.

According to report by Jiji Press, the woman was transferred to Kyoto University Hospital on Monday. In the surgery, carried out following a lung donation offer from her family, both of the woman’s lungs were removed, and part of her son’s right lung and part of her husband’s left lung were transplanted. The surgery took 10 hours and 57 minutes.

Since the surgery, the woman has been on a ventilator, but has come off ECMO. If things go smoothly, she will be able to leave hospital in two months and live normally a month after that, the hospital said.

According to professor Hiroshi Date at the hospital, who carried out the surgery, the woman’s lungs were fragile, and it was difficult to control the bleeding.

“In the sense that we now have a new option, I think this is a hopeful method of treatment for seriously ill patients (with coronavirus-induced pneumonia),” Date said.

Source: BERNAMA

Adib Mohd

Recent Posts

Cisco Secure AI Factory with NVIDIA Makes AI Easier to Deploy and Secure, Anywhere Organizations Need It

Cisco (NASDAQ: CSCO) today announced a major expansion of its Secure AI Factory with NVIDIA,… Read More

2 days ago

Take Style Cues from DK, SEUNGKWAN, and DINO with Skechers’ New Hotshot Collection

With SEVENTEEN continuing to shape global pop culture, Skechers taps into its influence to redefine… Read More

2 days ago

LG Electronics Unveil All-New, iF Award-Winning Indoor Unit Lineup for Water Heating Solutions

LG Electronics is turning up the heat, literally. At Mostra Convegno Expocomfort (MCE) 2026 in… Read More

2 days ago

Kuala Lumpur Convention Centre Malaysia’s First ISO 20121-Certified Purpose-Built Venue

The Kuala Lumpur Convention Centre (KLCC) just made history. It’s now Malaysia’s first purpose-built venue… Read More

2 days ago

A Season of Sweet Indulgence this Easter with Marks & Spencer

Marks & Spencer welcomes the Easter season with a deliciously indulgent collection of treats. These… Read More

3 days ago

Zurich Malaysia and Singapore x Project 1000, Turning Endurance into Empowerment Across Southeast Asia

Building on Zurich’s spirit of collaboration across Asia Pacific, Zurich Malaysia and Zurich Singapore have… Read More

3 days ago

This website uses cookies.